Publications

4536 Results

Genomic Alterations Important for the Prognosis in Patients with Follicular Lymphoma Treated on SWOG Study S0016

Authors
X Qu;H Li;R Braziel;V Passerini;L Rimsza;E Hsi;J Leonard;S Smith;R Kridel;O Weigert;M Leblanc;JW Friedberg;M Fang
Journal / Conference
Blood Jan 3;133(1):81-93; Nov 16 [Epub ahead of print]
Year
2019
Research Committee(s)
Lymphoma
PMID
PMID30446494
PMC
PMC6318431
Study Number(s)
S0016

The prevalence of HIV, Hepatitis B, and Hepatitis C among newly diagnosed cancer patients treated in academic and community oncology practices: SWOG S1204

Authors
S Ramsey;J Unger;L Baker;R Little;R Loomba;J Hwang;R Chugh;M Konerman;K Arnold;AR Menter;E Thomas;R Michels;C Walker Jorgensen;GV Burton;N Bhadkamkar;D Hershman
Journal / Conference
JAMA Oncology Jan 17. doi: 10.1001/jamaoncol.2018.6437. [Epub ahead of print]
Year
2019
Research Committee(s)
Cancer Care Delivery
PMID
PMID30653226
Study Number(s)
S1204

The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ ECOG-ACRIN Study (S0106 and E1900)

Authors
B Medeiros;M Othus;MS Tallman;Z Sun;HF Fernandez;JM Rowe;HM Lazarus;F Appelbaum;SM Luger;MR Litzow;H Erba
Journal / Conference
Leukemia Research Jan 17;78:29-33
Year
2019
Research Committee(s)
Leukemia
PMID
PMID30673620
Study Number(s)
S0106

What is the standard of care for pelvic lymphadenectomy performed at the time of radical cystectomy? [Editorial]

Authors
SP Lerner;RS Svatek
Journal / Conference
European Urology Jan 4. pii: S0302-2838(18)31034-0. doi: 10.1016/j.eururo.2018.12.028. [Epub ahead of print]
Year
2019
Research Committee(s)
Genitourinary
PMID
PMID30616946
Study Number(s)
S1011

SWOG S1505: Initial Findings on Eligibility and Neoadjuvant Chemotherapy Experience with mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

Authors
DPS Sohal;S McDonough;S Ahmad;N Gandhi;M Shaalan Beg;A Wang-Gillam;TBA;JL Wade, III;K Guthrie;A Lowy;P Philip;H Hochster
Journal / Conference
J Clin Oncol 37, 2019 (suppl 4; abstr 414); ASCO GI Cancers Symposium (Jan 17-19, 2019, San Francisco, CA), poster
Year
2019
Research Committee(s)
Gastrointestinal
Study Number(s)
S1505

Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci

Authors
L Sucheston-Campbell;A Clay;W Barlow;GT Budd;D Stram;C Haiman;X Sheng;L Yan;G Zirpoli;S Yao;C Jiang;K Owzar;D Hershman;KS Albain;D Hayes;H Moore;J Hobday;JA Stewart;C Isaacs;M Salim;J Gralow;G Hortobagyi;R Livingston;D Kroetz;C Ambrosone
Journal / Conference
Pharmacogenetics and Genomics Feb;28(2):49-55
Year
2018
Research Committee(s)
Breast
PMID
PMID29278617
PMC
PMC5824720
Study Number(s)
S0221

Tandem autologous hematopoietic cell transplantation for patients with primary progressive or recurrent hodgkin lymphoma: a SWOG and Blood & Marrow Transplant Clinical Trials Network phase II Trial (SWOG S0410/BMT CTN 0703)

Authors
EP Smith;H Li;J Friedberg;L Constine;L Rimsza;G Laport;L Popplewell;L Holmberg;SM Smith;SM Smith;M Leblanc;SJ Forman;RI Fisher;PJ Stiff
Journal / Conference
Biology of Blood and Marrow Transplantation Apr;24(4):700-707
Year
2018
Research Committee(s)
Lymphoma
PMID
PMID29289757
PMC
PMC5965270
Study Number(s)
S0410

An intergroup randomized phase II study of bevacizumab or cetuximab in combination with gemcitabine and in combination with chemoradiation (capecitabine and radiation) in patients with resected pancreatic carcinoma: a trial of the ECOG-ACRIN Cancer Research Group (E2204)

Authors
JD Berlin;Y Feng;P Feng;P Catalano;J Abbruzzese;P Philip;RR Mcwilliams;A Lowy;A Benson;W Blackstock
Journal / Conference
Oncology 94(1):39-46
Year
2018
Research Committee(s)
Gastrointestinal
PMID
PMID29040974
PMC
PMC5828967
Study Number(s)
CTSU/E2204

SWOG S0713: A phase II study of cetuximab added to induction chemotherapy of oxaliplatin and capecitabine, followed by neoadjuvant chemoradiation for locally advanced rectal cancer

Authors
C Leichman;S McDonough;S Smalley;K Billingsley;H Lenz;M Beldner;A Hezel;M Velasco;K Guthrie;C Blanke;H Hochster
Journal / Conference
Clinical Colorectal Cancer Mar;17(1):e121-e125; 2017 Oct 24 [Epub ahead of print]
Year
2018
Research Committee(s)
Gastrointestinal
PMID
PMID29233486
Study Number(s)
S0713

The scientific impact and value of large, NCI-sponsored randomized phase III cancer prevention trials

Authors
JM Unger;W Barlow;CM Tangen;SD Ramsey;IM Thompson;EA Klein;M LeBlanc;CD Blanke;P Goodman;LM Minasian;DL Hershman
Journal / Conference
Cancer Epidemiology Jun 21;55:117-122
Year
2018
Research Committee(s)
Cancer Control and Prevention
PMID
PMID29936140
PMC
PMC Journal - In Process
Study Number(s)
S0000, SWOG-9217